Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Net Margin (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of Net Margin data on record, last reported at 18325.64% in Q3 2020.

  • For Q3 2020, Net Margin fell 1715672.0% year-over-year to 18325.64%; the TTM value through Jun 2021 reached 31541.03%, down 3144416.0%, while the annual FY2025 figure was 10507.38%, N/A changed from the prior year.
  • Net Margin reached 18325.64% in Q3 2020 per COGT's latest filing, down from 1401.52% in the prior quarter.
  • Across five years, Net Margin topped out at 15.02% in Q4 2019 and bottomed at 18325.64% in Q3 2020.
  • Average Net Margin over 3 years is 2114.12%, with a median of 382.93% recorded in 2019.
  • The widest YoY moves for Net Margin: up 29626bps in 2020, down -1715672bps in 2020.
  • A 3-year view of Net Margin shows it stood at 226.18% in 2018, then surged by 107bps to 15.02% in 2019, then crashed by -122069bps to 18325.64% in 2020.
  • Per Business Quant database, its latest 3 readings for Net Margin were 18325.64% in Q3 2020, 1401.52% in Q2 2020, and 86.67% in Q1 2020.